Effects of drug-drug interactions involving oral antihyperglycaemics are, with the exception of hypoglycaemia, mostly clinically unimportant

Author： Adis International Limited

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.22, Iss.4, 2006-04, pp. : 18-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinically relevant drug–drug interactions between antiretrovirals and antifungals

By Vadlapatla Ramya Krishna Patel Mitesh Paturi Durga K Pal Dhananjay Mitra Ashim K

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 4, 2014-04 ,pp. : 561-580

Informa Healthcare

Access to resources Recommend Favorite

No clinically relevant drug–drug interactions when dalcetrapib is co-administered with atorvastatin

By Derks Michael Abt Markus Parr Graeme Meneses-Lorente Georgina Young Anne-Marie Phelan Mary

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 10, 2010-10 ,pp. : 1135-1145

Informa Healthcare

Access to resources Recommend Favorite

Antiparkinsonian Agents: Clinically Significant Drug Interactions and Adverse Effects, and Their Management

By Dalvi A. Ford B.

CNS Drugs, Vol. 9, Iss. 4, 1998-04 ,pp. : 291-310

Adis International

Access to resources Recommend Favorite

Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia

By Kostapanos Michael S. Milionis Haralampos J. Elisaf Moses S.

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 11-28

Adis International

Access to resources Recommend Favorite

Maraviroc potential drug-drug interactions

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite